Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Zivo Bioscience Inc
ZIVO | US
2.15
USD-0.05
-2.27%
ZIVO | US
Loading StockChartView...
About Zivo Bioscience Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
14/04/2026
Close
2.15
Open
2.30
High
2.30
Low
2.15
ZIVO Bioscience Inc. a research and development company engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal human and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors with an intellectual property portfolio comprising proprietary algal and bacterial strains biologically active molecules and complexes production techniques cultivation techniques and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health bovine mastitis canine joint health human immune modification algal biomass for human consumption and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products Inc. and changed its name to ZIVO Bioscience Inc. in October 2014. ZIVO Bioscience Inc. is headquartered in Bloomfield Hills Michigan.
View LessZIVO | US
Risk
260.6
Sharpe
-0.48
Luna's Score
42/100
Recommendation
Sell
Luna says (ZIVO | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
What's not Working
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
288.3%1 month
260.6%3 months
198.8%6 months
201.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
21.13
Debt to equity
-0.25
Debt to assets
1.00
Ent. to EBITDA
-3.01
Ent. to rev.
1.16K
PEG
-
Other Fundamentals
EBITDA
-
MarketCap
7.44M
MarketCap(USD)
7.44M
Div. yield
-
Op. margin
-21.87K
Erngs. growth
-
Rev. growth
-
Ret. on equity
-3.96K
Short ratio
6.65
Short perc.
2.61
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
4.96
Range1M
7.14
Range3M
9.91
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.15
Price X volume
1.51K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.01 | 0.53 | Cheaper |
| Ent. to Revenue | 1,159.48 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 21.13 | 15.55 | Expensive |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 198.82 | 72.80 | Riskier |
| Debt to Equity | -0.25 | -1.23 | Expensive |
| Debt to Assets | 1.00 | 0.25 | Expensive |
| Market Cap | 7.44M | 3.66B | Emerging |
